Suppression of hyperinsulinemia pro-tumoral effect [185]Reduced cell adhesion [185,186]Synergic cytotoxic effect with cetuximab [185]β-catenin suppression [187]Farnesylated Ras levels downregulation [188] Insulin levels downregulation [188]. The gene discussed is INS; the disease is hyperinsulinism.